Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PanGenex was a development-stage life sciences company primarily focused on the commercialization of proprietary, patent-protected nutraceuticals and functional foods. The company's lead product was Provinal, a highly purified palmitoleic acid (Omega-7) designed to address cardiovascular health by reducing systemic inflammation and improving lipid profiles. PanGenex targeted conditions such as metabolic syndrome and type 2 diabetes through its focus on C-reactive protein reduction. The company's assets and intellectual property were eventually integrated into Tersus Life Sciences, which continues to market the Provinal brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PanGenex.